Ulrik Kihlbom
About me
I am Professor of Medical Clinical Ethics in the Stockholm Centre for Healthcare Ethics, Department of Learning, Informatics, Management and Ethics (LIME), KI.
My primary research interests include ethical issues related to patients’ perspective and decision-making, the ethics of social care and public health, normative ethics and methodology of bioethics. I am the principal investigator of the interdisciplinary project "In the best interest of the child? Ethical, legal and empirical assessments of decisions in social service to restrict social contact", funden by the Swedish Research Council (2024-2026). It includes researchers from philosophy, public health, law and social work. I am also doing the ethics part in an ERAPerMed funded project, RELIABLE, in which we assess personalized preventive strategies for patients in the early stages of Multiple Sclerosis (MS), 2023-2025. I recently finalised a project that addressed patients’ views and the ethics of precision medicine in hematology within a European consortia, the 3-year project MEET-AML, funded by ERAPerMed.
I teach medical ethics at the medical school at KI, as well giving lectures and seminars for health care professionals around the country.
I am a member of the Ethics Council of Karolinska University Hospital, the Ethics council of Astrid Lindgren Children's Hospital, and the Scientific Advisory Committee for the Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU).
Articles
- Journal article: MULTIPLE SCLEROSIS AND RELATED DISORDERS. 2024;92:106143
- Article: PATIENT EDUCATION AND COUNSELING. 2023;115:107883
- Article: FRONTIERS IN PHARMACOLOGY. 2023;14:1192770
- Article: INTERNATIONAL JOURNAL OF QUALITATIVE STUDIES ON HEALTH & WELL-BEING. 2022;17(1):2103137
- Article: PATIENT EDUCATION AND COUNSELING. 2021;104(10):2577-2585
- Article: SCHIZOPHRENIA RESEARCH. 2021;228:360-366
- Article: RECENT RESULTS IN CANCER RESEARCH. 2021;218:119-134
- Article: PATIENT PREFERENCE AND ADHERENCE. 2021;15:1331-1345
- Article: ARTHRITIS RESEARCH & THERAPY. 2020;22(1):288
- Journal article: JOURNAL OF BIOETHICAL INQUIRY. 2020;17(4):749-755
- Article: BMC MEDICAL ETHICS. 2020;21(1):30
- Journal article: VALUE IN HEALTH. 2019;22(4):491-501
- Article: PATIENT PREFERENCE AND ADHERENCE. 2019;13:273-282
- Article: JOURNAL OF RISK RESEARCH. 2018;21(2):222-235
- Journal article: VALUE IN HEALTH. 2017;20(9):A540
- Journal article: JOURNAL OF ONCOLOGY PRACTICE. 2017;13(10):679-682
- Article: UPSALA JOURNAL OF MEDICAL SCIENCES. 2016;121(4):295-298
- Article: UPSALA JOURNAL OF MEDICAL SCIENCES. 2016;121(4):289-294
- Article: JOURNAL OF COMMUNITY GENETICS. 2016;7(3):203-214
- Article: EUROPEAN JOURNAL OF CANCER CARE. 2016;25(3):516-523
- Article: JOURNAL OF MEDICAL ETHICS. 2015;41(2):183-185
- Article: EUROPEAN JOURNAL OF CANCER CARE. 2015;24(1):133-141
- Article: SUPPORTIVE CARE IN CANCER. 2013;21(11):3137-3142
- Journal article: PHYSICAL CULTURE AND SPORT, STUDIES AND RESEARCH. 2013;59(1):21-32
- Journal article: SPORT, ETHICS AND PHILOSOPHY. 2012;6(4):467-479
- Journal article: SPORT, ETHICS AND PHILOSOPHY. 2011;5(2):149-160
- Article: ACTA PAEDIATRICA, INTERNATIONAL JOURNAL OF PAEDIATRICS. 2009;98(8):1349-1354
- Article: JOURNAL OF MEDICAL ETHICS. 2008;34(3):146-149
- Article: BMC MEDICAL ETHICS. 2007;8:6
- Show more
All other publications
- Book chapter: ETHICAL CHALLENGES IN CANCER DIAGNOSIS AND THERAPY: RECENT RESULTS IN CANCER RESEARCH. 2021;p. 119-134Ethical Aspects of Regulating Oncology Products
- Book: 2020Ethical, Social and Psychological Impacts of Genomic Risk Communication
- Book chapter: ETHICAL, SOCIAL AND PSYCHOLOGICAL IMPACTS OF GENOMIC RISK COMMUNICATION. 2020;p.Introduction
- Book chapter: ETHICAL, SOCIAL AND PSYCHOLOGICAL IMPACTS OF GENOMIC RISK COMMUNICATION. 2020;p."They don't really understand"
- Book chapter: ETHICAL, SOCIAL AND PSYCHOLOGICAL IMPACTS OF GENOMIC RISK COMMUNICATION. 2020;p.Epilogue
- Book chapter: WHAT ABOUT THE FAMILY? PRACTICES OF RESPONSIBILITY IN CARE. 2019;p.Healthcare Decisions
- Review: PROGRESS IN MOLECULAR BIOLOGY AND TRANSLATIONAL SCIENCE. 2018;158:299-323
- Published conference paper: BIOETHICS. 2000;14(4):287-309
Grants
- Swedish Research Council1 January 2024 - 31 December 2026
- RELIABLE (Targeting subclinical motor and cognitive impairment in patients with early onset Multiple Sclerosis at high Risk of disEase acitivity through a preventive personaLised and InnovAtive rehaBiLitation stratEgy)ERA PerMed/Vinnova1 March 2022 - 28 February 2025
- Swedish Research Council1 January 2021 - 31 December 2022
- Swedish Research Council1 January 2020 - 31 December 2022
- Innovative Medicines Initiative (IMI) 21 October 2016 - 31 May 2022